Table 2.
Total samplea (N = 207) | Relapse at the start of second-line treatment | p value | ||
---|---|---|---|---|
Biochemical (N = 139) | Clinical (N = 67) | |||
Response | N (%) | N (%) | N (%) | 0.021 |
sCRb | 10 (4.8) | 6 (4.3) | 4 (6.0) | |
CRc | 27 (13.0) | 15 (10.8) | 12 (17.9) | |
VGPRd | 49 (23.7) | 36 (25.9) | 13 (19.4) | |
PRe | 66 (31.9) | 51 (36.7) | 15 (22.4) | |
MRf/SDg | 16 (7.7) | 12 (8.6) | 4 (6.0) | |
Other | 39 (18.9) | 19 (13.7) | 19 (28.4) | |
ORRh | 152 (73.4) | 108 (77.7) | 44 (65.7) | 0.066 |
aType of relapse unknown for one patient
bStringent complete response
cComplete response
dVery good partial response
ePartial response
fMinor response
gStable disease
hOverall response rate